Your browser doesn't support javascript.
loading
Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting.
Mittelman, Moshe; Magen, Ori; Barda, Noam; Dagan, Noa; Oster, Howard S; Leader, Avi; Balicer, Ran.
Afiliação
  • Mittelman M; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Magen O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Barda N; Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
  • Dagan N; Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
  • Oster HS; Department of Software and Information Systems Engineering, Ben Gurion University, Be'er Sheva, Israel.
  • Leader A; Department of Biomedical Informatics, Harvard Medical School, Boston, MA.
  • Balicer R; The Ivan and Francesca Berkowitz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute, Tel Aviv, Israel.
Blood ; 139(10): 1439-1451, 2022 03 10.
Article em En | MEDLINE | ID: mdl-34662390
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article